2023 ACR/EULAR AntiPhospholipid Syndrome (APS) classification criteria

Short description
The webinar is disease-specific and targeting healthcare professionals (HCPs). In particular, it focused on a critical overview on the recently developed new antiphospholipid syndrome (APS) classification criteria, jointly supported by the American College of Rheumatology (ACR) and EULAR.
Speaker
Professor Stéphane Zuily is a cardiovascular specialist in the Department of Vascular Medicine at Nancy Academic Hospital. His clinical activities include the management of all common vascular diseases (e.g. thrombosis, PAD, aneurysms, acrosyndrome) as well as rare diseases of arteries, veins, lymphatics and microcirculation. His research activities are oriented towards thrombosis especially the antiphospholipid syndrome. He's the national investigator coordinator in charge of the COVI-DOSE trial (NCT04373707) identifying the best anticoagulant strategy to prevent thrombosis in COVID-19 patients. He is the vice-president of the Conseil National Professionnel of Vascular Medicine, general secretary (2017-2020) of the French Society of Vascular Medicine and is a member of several scientific societies (SFC, SFMV, ESC, ISTH).
More info about APS can be found here: reconnet.ern-net.eu/disease-aps/
The registration to the ERN ReCONNET Newsletter can be done following this link:
reconnet.ern-net.eu/event-and-media-newsletter/

[@elainemcnabb2587]

I'm 68yrs and I found out that I have anti phospholipid antibodies syndrome 2023 of September

[@reneehughes6985]

Nephew 14yrs diagnosed. Had 2 jabs. I bet your getting alot more cases now.
Bet you didn't even look at the experimental meds everyone was forced to have. Shame.